Skip to main content

Protein Discovery, Roch Kelly, Nina Fedoroff, David Harvey, Lee McCollum, Jai Nagarkatti, Avi Nash, William O Neil, Pedro Reinhard, Timothy Sear, Dean Spatz, Barrett Toan, Remco van Soest

Premium

New Products

Protein Discovery introduced this week PPS Silent Surfactant, an acid-cleavable detergent for cell membrane disruption and protein solubilization. According to the company, the new reagent offers the same detergent properties as conventional surfactants, but when it is no longer needed, it degrades into easily removed compounds with no detergent activity, instead of retaining foaming and other detergent properties that interfere with the final stages of mass spectrometry sample preparation.

 

Movers & Shakers

Protedyne has tapped Roch Kelly as chief operating officer. Kelly will head the company's manufacturing, purchasing, customer care, and human resources departments.

Kelly was most recently vice president of clinical operations, North America and worldwide business operations, for Paraxel International. Prior to that, he was executive director of manufacturing operations at Chiron Diagnostics.

He holds a BS in Finance from Miami University and an MBA from Syracuse University.


Sigma-Aldrich re-elected several directors at its annual shareholders meeting last week: Nina Fedoroff, David Harvey, Lee McCollum, Jai Nagarkatti, Avi Nash, William O'Neil, Pedro Reinhard, Timothy Sear, Dean Spatz, and Barrett Toan.


Remco van Soest has joined Eksigent Technologies as product manager of the company's NanoLC HPLC systems. In this role, he will lead development of tools for proteomics and biomarker discovery, and will be responsible for marketing the company's NanoLC-1D Plus and NanoLC-2D proteomics systems.

Most recently, van Soest was technical manager at Dionex. Prior to that, he was research scientist at LC Packings. He holds an MS in analytical chemistry from Vrije Universiteit the Netherlands.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.